Company Filing History:
Years Active: 2019
Title: Innovations of Stefan Reinelt
Introduction
Stefan Reinelt is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Reinelt holds a patent for "Substituted mono- and polyazanaphthalene derivatives and their use." This patent discloses compounds that are useful for the treatment of proliferation disorders or diseases, such as cancer. The compounds are characterized by a complex formula that includes various substituents and functional groups, making them versatile in their application.
Career Highlights
Stefan Reinelt is associated with Basilea Pharmaceutica International AG, a company known for its focus on innovative medicines. His work at Basilea has allowed him to contribute to the advancement of pharmaceutical research and development.
Collaborations
Reinelt has collaborated with notable colleagues, including Jens Pohlmann and Martin Stieger. These collaborations have likely enhanced the research and development efforts within his field.
Conclusion
Stefan Reinelt's innovative work in pharmaceuticals, particularly through his patent on substituted derivatives, showcases his commitment to advancing medical science. His contributions are significant in the ongoing fight against diseases like cancer.